Modern Chinese Medicine Faces 90.6% Shareholding Concentration as SFC Flags Market Risk

Bulletin Express04-14

Modern Chinese Medicine Group Co., Ltd. (Modern Chinese Medicine) announced that the Securities and Futures Commission (SFC) has identified a high concentration of ownership in the company’s shares. As of 30 March 2026, 25 shareholders and their related parties controlled 652.33 million shares, representing 90.60 % of the 720.00 million shares in issue. Only 67.67 million shares, or 9.40 %, remained in the hands of other shareholders.

During the period under review, the company’s share price surged 316 %, rising from HK$0.51 on 31 December 2025 to HK$2.12 on 30 March 2026. The upward trend continued, and the price closed at HK$2.94 on 13 April 2026, marking a cumulative increase of 476 % since 31 December 2025.

Modern Chinese Medicine confirmed that, to the best of directors’ knowledge, no less than 25 % of its shares were held by the public both on 30 March 2026 and on the date of the announcement, meeting Hong Kong Stock Exchange listing rules.

The board highlighted that the limited free float could lead to substantial price volatility even on low trading volumes and urged shareholders and potential investors to exercise extreme caution. The disclosure follows an enquiry by the SFC into the company’s shareholding structure.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1193650061?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-14 23:04","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1193650061","market":"hk","top_or_hot":-1,"title":"Modern Chinese Medicine Faces 90.6% Shareholding Concentration as SFC Flags Market Risk","media":"Bulletin Express","content":"<p>Modern Chinese Medicine Group Co., Ltd. (Modern Chinese Medicine) announced that the Securities and Futures Commission (SFC) has identified a high concentration of ownership in the company’s shares. As of 30 March 2026, 25 shareholders and their related parties controlled 652.33 million shares, representing 90.60 % of the 720.00 million shares in issue. Only 67.67 million shares, or 9.40 %, remained in the hands of other shareholders.</p>\n<p>During the period under review, the company’s share price surged 316 %, rising from HK$0.51 on 31 December 2025 to HK$2.12 on 30 March 2026. The upward trend continued, and the price closed at HK$2.94 on 13 April 2026, marking a cumulative increase of 476 % since 31 December 2025.</p>\n<p>Modern Chinese Medicine confirmed that, to the best of directors’ knowledge, no less than 25 % of its shares were held by the public both on 30 March 2026 and on the date of the announcement, meeting Hong Kong Stock Exchange listing rules.</p>\n<p>The board highlighted that the limited free float could lead to substantial price volatility even on low trading volumes and urged shareholders and potential investors to exercise extreme caution. The disclosure follows an enquiry by the SFC into the company’s shareholding structure.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Modern Chinese Medicine Faces 90.6% Shareholding Concentration as SFC Flags Market Risk</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModern Chinese Medicine Faces 90.6% Shareholding Concentration as SFC Flags Market Risk\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-04-14 23:04</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Modern Chinese Medicine Group Co., Ltd. (Modern Chinese Medicine) announced that the Securities and Futures Commission (SFC) has identified a high concentration of ownership in the company’s shares. As of 30 March 2026, 25 shareholders and their related parties controlled 652.33 million shares, representing 90.60 % of the 720.00 million shares in issue. Only 67.67 million shares, or 9.40 %, remained in the hands of other shareholders.</p>\n<p>During the period under review, the company’s share price surged 316 %, rising from HK$0.51 on 31 December 2025 to HK$2.12 on 30 March 2026. The upward trend continued, and the price closed at HK$2.94 on 13 April 2026, marking a cumulative increase of 476 % since 31 December 2025.</p>\n<p>Modern Chinese Medicine confirmed that, to the best of directors’ knowledge, no less than 25 % of its shares were held by the public both on 30 March 2026 and on the date of the announcement, meeting Hong Kong Stock Exchange listing rules.</p>\n<p>The board highlighted that the limited free float could lead to substantial price volatility even on low trading volumes and urged shareholders and potential investors to exercise extreme caution. The disclosure follows an enquiry by the SFC into the company’s shareholding structure.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01643","symbol_name":"现代中药集团","start_time":0,"source_url":"","article_id":"1193650061","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1193650061","pubTimestamp":1776179057,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Modern Chinese Medicine Group Co., Ltd. (Modern Chinese Medicine) announced that the Securities and Futures Commission (SFC) has identified a high concentration of ownership in the company’s shares....","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01643":"现代中药集团"},"translate_title":"证监会标记市场风险，现代中药面临90.6%股权集中度","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01643":1},"content_text":"Modern Chinese Medicine Group Co., Ltd. (Modern Chinese Medicine) announced that the Securities and Futures Commission (SFC) has identified a high concentration of ownership in the company’s shares. As of 30 March 2026, 25 shareholders and their related parties controlled 652.33 million shares, representing 90.60 % of the 720.00 million shares in issue. Only 67.67 million shares, or 9.40 %, remained in the hands of other shareholders.\nDuring the period under review, the company’s share price surged 316 %, rising from HK$0.51 on 31 December 2025 to HK$2.12 on 30 March 2026. The upward trend continued, and the price closed at HK$2.94 on 13 April 2026, marking a cumulative increase of 476 % since 31 December 2025.\nModern Chinese Medicine confirmed that, to the best of directors’ knowledge, no less than 25 % of its shares were held by the public both on 30 March 2026 and on the date of the announcement, meeting Hong Kong Stock Exchange listing rules.\nThe board highlighted that the limited free float could lead to substantial price volatility even on low trading volumes and urged shareholders and potential investors to exercise extreme caution. The disclosure follows an enquiry by the SFC into the company’s shareholding structure.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1193650061","isCrawlerRequest":true}